Adriamycin is a potent antitumor antibiotic commonly used in chemotherapy.
阿霉素是一种强效抗肿瘤抗生素,常用于化疗。
The patient's response to
adriamycin was remarkable, with a significant shrinkage of the tumor.
患者对阿霉素的反应显著,肿瘤明显缩小。
She underwent a series of
adriamycin treatments for her breast cancer, which were well-tolerated.
她因乳腺癌接受了阿霉素的一系列治疗,副作用较小。
Doctors often prescribe a combination of doxorubicin (another name for
adriamycin) and cyclophosphamide for advanced ovarian cancer.
医生通常会为晚期卵巢癌患者开具阿霉素(doxorubicin的别名)和环磷酰胺的联合疗法。
Adriamycin-induced cardiotoxicity is a known side effect, so patients are closely monitored during treatment.
阿霉素引起的心脏毒性是已知的副作用,因此在治疗期间患者会受到严密监控。
The researchers observed that
adriamycin was more effective when combined with radiotherapy in treating lung cancer.
研究者发现,阿霉素与放疗结合治疗肺癌时效果更佳。
The doctor recommended a lower dose of
adriamycin to minimize the risk of severe side effects for the elderly patient.
医生建议降低老年患者的阿霉素剂量以减少严重副作用的风险。
After completing
adriamycin therapy, the patient began a maintenance regimen of oral chemotherapy.
完成阿霉素治疗后,患者开始口服化疗维持治疗。
Adriamycin is a first-line drug for treating many types of aggressive cancers, including Hodgkin's lymphoma.
阿霉素是治疗多种侵袭性癌症的一线药物,包括霍奇金淋巴瘤。
The development of resistance to
adriamycin is a major concern in cancer chemotherapy, as it can limit treatment options.
对阿霉素产生耐药性是癌症化疗的一大挑战,因为它可能限制治疗选择。
未经许可,严禁转发。QQ交流群:688169419